The Discovery of inhibitors of the SARS-CoV-2 S protein through computational drug repurposing
Open Access
- 14 February 2024
- journal article
- research article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 171, 108163
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- European Commission
- Generalitat de Catalunya Agencia de Gestio d'Ajuts Universitaris i de Recerca
- Junta de Andalucía
This publication has 53 references indexed in Scilit:
- MMPBSA.py: An Efficient Program for End-State Free Energy CalculationsJournal of Chemical Theory and Computation, 2012
- Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with ReceptorScience, 2005
- Validation and Use of the MM-PBSA Approach for Drug DiscoveryJournal of Medicinal Chemistry, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structuresJournal of Computational Chemistry, 2003
- Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–RafJournal of Computational Chemistry, 2003
- TelmisartanDrugs, 1998
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983
- Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanesJournal of Computational Physics, 1977